IL-2 and autoimmune disease

Cytokine and Growth Factor Reviews

Volumn 13, Issue 4-5, 2002, Pages 369-378

  Schimpl, Anneliese ^a   Berberich, Ingolf ^a   Kneitz, Burkhardt ^a   Krämer, Susanne ^a   Santner Nanan, Brigitte ^a   Wagner, Sabine ^a   Wolf, Martina ^a   Hünig, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Activation induced cell death; Autoimmune disease; IL 2 deficiency; T cell growth factor

Indexed keywords

CD38 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DEATH; DENDRITIC CELL; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFLAMMATION; INTERLEUKIN 2 DEFICIENCY SYNDROME; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THYMUS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CELL MOVEMENT; CLONAL DELETION; DENDRITIC CELLS; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-2; SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 0036695190     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(02)00022-9     Document Type: Review

References (55)

1. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352:621-4.
2. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
3. Suzuki H, Kundig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995;268:1472-6.
4. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3:521-30.
5. Horak I, Lohler J, Ma A, Smith KA. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 1995;148:35-44.
6. Hunig T, Schimpl A. The IL-2 deficiency syndrome: a lethal disease caused by abnormal lymphocyte survival. In: Durum SK, Muegge K, editors. Cytokine knockouts. Totowa, NJ: Humana Press, 1998. p. 1-19.
7. Krämer S, Schimpl A, Hunig T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995;182:1769-76.
8. + T cells. Eur J Immunol 1995;25:3053-9.
9. Ehrhardt RO, Ludviksson BR, Gray B, Neurath M, Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997;158:566-73.
10. + T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 2001;31:1637-45.
11. Krämer S, Mamalaki C, Horak I, Schimpl A, Kioussis D, Hung T. Thymic selection and peptide-induced activation of T cell receptor-transgenic CD8 T cells in interleukin-2-deficient mice. Eur J Immunol 1994;24:2317-22.
12. Bassiri H, Carding SR. A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection. J Immunol 2001;166:5945-54.
13. Kishimoto H, Surh CD, Sprent J. A role for Fas in negative selection of thymocytes in vivo. J Exp Med 1998;187:1427-38.
14. Lenardo MJ. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991;353:858-61.
15. Kneitz B, Herrmann T, Yonehara S, Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and energy induction in interleukin-2-deficient mice. Eur J Immunol 1995;25:2572-7.
16. Renno T, Hahne M, MacDonald HR. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 1995;181:2283-7.
17. Krammer PH. CD95s deadly mission in the immune system. Nature 2000;407:789-95.
18. Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nature Rev Immunol 2001;1:50-8.
19. Kataoka T, Budd RC, Holler N, et al. The caspase-8 inhibitor FLIP promotes activation of NFκB and Erk signaling pathways. Curr Biol 2000;10:640-8.
20. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.
21. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Ann Rev Immunol 1998;16:395-419.
22. Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998;8:615-23.
23. Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 1995;154:4395-403.
24. Cheng EH, Kirsch DG, Clem RJ, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997;278:1966-8.
25. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990;172:921-9.
26. + T cells from interleukin-2 deficient mice towards Th1 and Th2 in the absence of exogenous interleukin-2. Eur Cytokine Netw 1998;9:17-25.
27. Sadlack B, Kuhn R, Schorle H, Rajewsky K, Muller W, Horak I. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 1994;24:281-4.
28. Waidmann M, Allemand Y, Lehmann J, et al. Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-γ and TNF-α production. Gut 2002;50:170-9.
29. Ludviksson BR, Ehrhardt RO, Strober W. TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 1997;159:3622-8.
30. Nagata S, Suda T. Fas and Fas ligand: 1pr and gld mutations. Immunol Today 1995;16:39-43.
31. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
32. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387-96.
33. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000;21:95-9.
34. + regulatory T cells: their common role in controlling autoimmunity, tumour immunity, and transplantation tolerance. Immunol Rev 2001;182:18-32.
35. Singh B, Read S, Asseman C, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
36. Annacker O, Burlen-Defranoux O, Pimenta-Araujo R, Cumano A, Bandeira A. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J Immunol 2000;164:3573-80.
37. + T cells: a common basis between tumour immunity and autoimmunity. J Immunol 1999;163:5211-8.
38. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994;78:399-408.
39. Furtado GC, Olivares-Villagomez D, Curotto De Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ. Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol Rev 2001;182:122-34.
40. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-40.
41. + and CD25-subpopulations. J Immunol 2000;165:3105-10.
42. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-96.
43. + T cells. J Exp Med 1996;183:2669-74.
44. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
45. Klebb G, Autenrieth IB, Haber H, et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 1996;81:282-6.
46. Malek TR, Porter BO, Codias EK, Scibelli P, Yu A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J Immunol 2000;164:2905-14.
47. Li XC, Demirci G, Ferrari-Lacraz S, et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001;7:114-8.
48. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualisation of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-39.
49. Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med 1999;190:1561-72.
50. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells: expression of IL-2Rα chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998;10:371-8.
51. Plaetinck G, Combe MC, Corthesy P, et al. Control of IL-2 receptor-alpha expression by IL-1, tumour necrosis factor, and IL-2. Complex regulation via elements in the 5′ flanking region. J Immunol 1990;145:3340-7.
52. Granucci F, Vizzardelli C, Pavelka N, et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2001;2:882-8.
53. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000;30:1813-22.
54. Petitto JM, Streit WJ, Huang Z, Butfiloski E, Schiffenbauer J. Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice. Neurosci Lett 2000;285:66-70.
55. Carlow DA, Corbel SY, Williams MJ, Ziltener HJ, IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells. J Immunol 2001;167:6841-8.